Brain proteome profiling implicates the complement and coagulation cascade in multiple system atrophy brain pathology
Authors:
- Rasmus RydbirkRRRasmus Rydbirk
- Ole ØstergaardOØOle Østergaard
- Jonas FolkeJFJonas Folke
- Casper HempelCHCasper Hempel
- Brian DellaValleBDBrian DellaValle
- Thomas L. AndresenTAThomas L. Andresen
- Annemette LøkkegaardALAnnemette Løkkegaard
- Anne-Mette HejlAHAnne-Mette Hejl
- Matthias BodeMBMatthias Bode
- Morten BlaabjergMBMorten Blaabjerg
- Mette MøllerMMMette Møller
- Erik H. DanielsenEDErik H. Danielsen
- 3 June 2022
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (6) , 1-22
Abstract
Background Multiple system atrophy (MSA) is a rare, progressive, neurodegenerative disorder presenting glia pathology. Still, disease etiology and pathophysiology are unknown, but neuro-inflammation and vascular disruption may be contributing factors to the disease progression. Here, we performed an ex vivo deep proteome profiling of the prefrontal cortex of MSA patients to reveal disease-relevant molecular neuropathological processes. Observations were validated in plasma and cerebrospinal fluid (CSF) of novel cross-sectional patient cohorts. Methods Brains from 45 MSA patients and 30 normal controls (CTRLs) were included. Brain samples were homogenized and trypsinized for peptide formation and analyzed by high-performance liquid chromatography tandem mass spectrometry (LC–MS/MS). Results were supplemented by western blotting, immuno-capture, tissue clearing and 3D imaging, immunohistochemistry and immunofluorescence. Subsequent measurements of glial fibrillary acid protein (GFAP) and neuro-filament light chain (NFL) levels were performed by immunoblotting in plasma of 20 MSA patients and 20 CTRLs. Finally, we performed a proteome profiling of 144 CSF samples from MSA and CTRLs, as well as other parkinsonian disorders. Data were analyzed using relevant parametric and non-parametric two-sample tests or linear regression tests followed by post hoc tests corrected for multiple testing. Additionally, high-throughput bioinformatic analyses were applied. Results We quantified more than 4,000 proteins across samples and identified 49 differentially expressed proteins with significantly different abundances in MSA patients compared with CTRLs. Pathway analyses showed enrichment of processes related to fibrinolysis and complement cascade activation. Increased fibrinogen subunit β (FGB) protein levels were further verified, and we identified an enriched recognition of FGB by IgGs as well as intra-parenchymal accumulation around blood vessels. We corroborated blood–brain barrier leakage by a significant increase in GFAP and NFL plasma levels in MSA patients that correlated to disease severity and/or duration. Proteome profiling of CSF samples acquired during the disease course, confirmed increased total fibrinogen levels and immune-related components in the soluble fraction of MSA patients. This was also true for the other atypical parkinsonian disorders, dementia with Lewy bodies and progressive supra-nuclear palsy, but not for Parkinson’s disease patients. Conclusion Our results implicate activation of the fibrinolytic cascade and immune system in the brain as contributing factors in MSA associated with a more severe disease course.Keywords
Funding Information
- Novo Nordisk Fonden (NNF14CC0001)
- Lundbeck Foundation (R218-2016-947, R221-2016-1345)
- Hartmann Fonden
- Oda og Hans Svenningsens Fond
- Hørslev-Fonden
- Jascha Fonden
- Danish Movement Disorder Society
- Parkinsonforeningen
- Bispebjerg Hospital Research Foundation
- Multiple System Atrophy Association
This publication has 80 references indexed in Scilit:
- Extracellular matrix and matrix receptors in blood–brain barrier formation and strokeDevelopmental Neurobiology, 2011
- Global quantification of mammalian gene expression controlNature, 2011
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant EnvironmentJournal of Proteome Research, 2011
- Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerizationProceedings of the National Academy of Sciences, 2010
- Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's DiseaseNeuron, 2010
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTipsNature Protocols, 2007
- Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosisNeurobiology of Disease, 2005
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- ParkinsonismNeurology, 1967